“Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy With Omalizumab in Patients With Chronic Idiopathic Spontaneous Urticaria (CIU CSU)”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S51. https://doi.org/10.25251/skin.2.supp.51.